Alnylam Pharmaceuticals
ALNY
#581
Rank
$34.74 B
Marketcap
$268.46
Share price
-0.94%
Change (1 day)
79.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company